Mavens Biotech standalone net profit declines 50.00% in the September 2016 quarter
Sales rise 66.67% to Rs 0.35 crore
Net profit of Mavens Biotech declined 50.00% to Rs 0.01 crore in the quarter ended September 2016 as against Rs 0.02 crore during the previous quarter ended September 2015. Sales rose 66.67% to Rs 0.35 crore in the quarter ended September 2016 as against Rs 0.21 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales0.350.21 67 OPM %11.4328.57 -PBDT0.040.06 -33 PBT0.010.02 -50 NP0.010.02 -50Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content